Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption.

Frontiers in physiology

Chi OZ, Liu X, Cofano S, Patel N, Jacinto E, Weiss HR.
PMID: 34354602
Front Physiol. 2021 Jul 20;12:706528. doi: 10.3389/fphys.2021.706528. eCollection 2021.

It has been reported that the mechanistic target of rapamycin (mTOR) pathway is involved in cerebral ischemia-reperfusion injury. One of the important pathological changes during reperfusion after cerebral ischemia is disruption of blood-brain barrier (BBB). Rapamycin, a first-generation mTOR...

Cite
Chi OZ, Liu X, Cofano S, et al. Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption. Front Physiol. 2021;12:706528doi: 10.3389/fphys.2021.706528.
Chi, O. Z., Liu, X., Cofano, S., Patel, N., Jacinto, E., & Weiss, H. R. (2021). Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption. Frontiers in physiology, 12706528. https://doi.org/10.3389/fphys.2021.706528
Chi, Oak Z, et al. "Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption." Frontiers in physiology vol. 12 (2021): 706528. doi: https://doi.org/10.3389/fphys.2021.706528
Chi OZ, Liu X, Cofano S, Patel N, Jacinto E, Weiss HR. Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption. Front Physiol. 2021 Jul 20;12:706528. doi: 10.3389/fphys.2021.706528. eCollection 2021. PMID: 34354602; PMCID: PMC8329705.
Copy Download .nbib Format: NLM
Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption.

Neuroscience letters

Chi OZ, Chiricolo A, Liu X, Patel N, Jacinto E, Weiss HR.
PMID: 34332027
Neurosci Lett. 2021 Sep 25;762:136143. doi: 10.1016/j.neulet.2021.136143. Epub 2021 Jul 29.

Blood-brain barrier (BBB) disruption is one of the most important pathological changes following cerebral ischemia-reperfusion. We tested whether inhibition of the serum and glucocorticoid regulated kinase 1 (SGK1) would decrease BBB disruption and contribute to decreasing infarct size in...

Cite
Chi OZ, Chiricolo A, Liu X, et al. Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption. Neurosci Lett. 2021;762:136143doi: 10.1016/j.neulet.2021.136143.
Chi, O. Z., Chiricolo, A., Liu, X., Patel, N., Jacinto, E., & Weiss, H. R. (2021). Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption. Neuroscience letters, 762136143. https://doi.org/10.1016/j.neulet.2021.136143
Chi, Oak Z, et al. "Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption." Neuroscience letters vol. 762 (2021): 136143. doi: https://doi.org/10.1016/j.neulet.2021.136143
Chi OZ, Chiricolo A, Liu X, Patel N, Jacinto E, Weiss HR. Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption. Neurosci Lett. 2021 Sep 25;762:136143. doi: 10.1016/j.neulet.2021.136143. Epub 2021 Jul 29. PMID: 34332027; PMCID: PMC8434992.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries